Primary Failure to an Anti-TNF Agent in Inflammatory Bowel Disease: Switch (to a Second Anti-TNF Agent) or Swap (for Another Mechanism of Action)?

Background: About a third of patients with inflammatory bowel disease do not respond to anti-tumour necrosis factor (anti-TNF) therapy, which is challenging. Aim: To review the current data on the two main strategies when facing primary non-response to an anti-TNF agent in inflammatory bowel disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Gisbert, Javier P., Chaparro, María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625924/
https://www.ncbi.nlm.nih.gov/pubmed/34830595
http://dx.doi.org/10.3390/jcm10225318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625924/
https://www.ncbi.nlm.nih.gov/pubmed/34830595
http://dx.doi.org/10.3390/jcm10225318

Ejemplares similares